BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6385345)

  • 1. Influence of vagotomy upon GIP release in patients with peptic ulcer.
    Imamura M; Kameyama J; Naito H; Sato T; Ohneda A
    Tohoku J Exp Med; 1984 Jul; 143(3):335-44. PubMed ID: 6385345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of gastric inhibitory polypeptide and insulin in response to intrajejunal glucose in duodenal ulcer patients before and after truncal vagotomy.
    Lauritsen KB; Moesgaard F; Nielsen ML; Jensen SL
    Scand J Gastroenterol; 1982 Jun; 17(4):507-11. PubMed ID: 6753107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of truncal vagotomy on GIP release induced by intraduodenal glucose or fat in dogs.
    Yoshiya K; Yamamura T; Ishikawa Y; Utsunomiya J; Takemura J; Takeda J; Seino Y; Imura H
    Digestion; 1985; 31(1):41-6. PubMed ID: 3979679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
    Lauritsen KB; Moody AJ
    Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
    Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intragastric ethanol administration on gastric acid secretion and gastrointestinal hormone release in dogs.
    Imamura M; Sasaki I; Tsuchiya T; Sato T
    Tohoku J Exp Med; 1985 Nov; 147(3):247-59. PubMed ID: 3937294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.
    Takemura J; Seino Y; Yamamura T; Yoshiya K; Ishikawa Y; Itoh N; Imura H
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):345-53. PubMed ID: 6354520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis.
    Lawaetz O; Blackburn AM; Bloom SR; Aritas Y; Ralphs DN
    Scand J Gastroenterol; 1983 Jan; 18(1):73-80. PubMed ID: 6372067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
    Cataland S; O'Dorisio TM; Crockett SE; Mekhjian HS
    J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients.
    Lauritsen KB; Frederiksen HJ; Uhrenholdt A; Holst JJ
    Scand J Gastroenterol; 1982 Jun; 17(4):513-6. PubMed ID: 6753108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of truncal vagotomy on serum- GIP and glucose homeostasis (author's transl)].
    Schafmayer A; Ebert R; Becker HD
    Z Gastroenterol; 1979 Aug; 17(8):511-7. PubMed ID: 506354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of selective proximal vagotomy on gastrin, GIP and insulin blood levels in patients with duodenal ulcer].
    Börger HW; Schafmayer A; Becker HD
    Chir Forum Exp Klin Forsch; 1978; (1978):25-9. PubMed ID: 752595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.
    Lauritsen KB; Moody AJ; Christensen KC; Lindkaer Jensen S
    Scand J Gastroenterol; 1980; 15(7):833-40. PubMed ID: 7010526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
    Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
    Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of gastric inhibitory polypeptide to inhibit pentagastrin-stimulated acid secretion in vagotomized human subjects.
    Simmons TC; Taylor IL; Maxwell V; Brown JC; Grossman MI
    Dig Dis Sci; 1981 Oct; 26(10):902-4. PubMed ID: 6793335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
    Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vagotomy on gastrointestinal hormones.
    Becker HD; Börger HW; Schafmayer A
    World J Surg; 1979 Sep; 3(5):615-22. PubMed ID: 390900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls.
    Jorde R; Schulz TB; Burhol PG; Schulz LB
    Regul Pept; 1981 Nov; 2(6):391-9. PubMed ID: 7029674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
    Crockett SE; Mazzaferri EL; Cataland S
    Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endogenous gastric inhibitory polypeptide in the enteroinsular axis.
    Takemura J; Seino Y; Yamamura T; Tsuda K; Seino S; Itoh N; Imura H
    J Clin Endocrinol Metab; 1982 May; 54(5):909-13. PubMed ID: 7037822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.